Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
2.170
-0.070 (-3.13%)
At close: Jun 27, 2025, 4:00 PM
2.200
+0.030 (1.38%)
After-hours: Jun 27, 2025, 6:43 PM EDT
Immix Biopharma Market Cap
Immix Biopharma has a market cap or net worth of $60.44 million as of June 27, 2025. Its market cap has increased by 10.54% in one year.
Market Cap
60.44M
Enterprise Value
45.58M
1-Year Change
10.54%
Ranking
Category
Stock Price
$2.17
Market Cap Chart
Since the IPO on December 16, 2021, Immix Biopharma's market cap has decreased from $65.74M to $60.44M, a decrease of -8.07%. That is a compound annual growth rate of -2.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 62.39M | 3.09% |
| Dec 31, 2024 | 60.52M | -55.98% |
| Dec 29, 2023 | 137.48M | 331.07% |
| Dec 30, 2022 | 31.89M | -32.18% |
| Dec 31, 2021 | 47.02M | -28.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 712.83B |
| Johnson & Johnson | 367.31B |
| AbbVie | 328.05B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 274.59B |
| Abbott Laboratories | 239.28B |
| Novartis AG | 231.01B |
| AstraZeneca | 218.32B |